Literature DB >> 16973554

Revealing domain structure through linker-scanning analysis of the murine leukemia virus (MuLV) RNase H and MuLV and human immunodeficiency virus type 1 integrase proteins.

Jennifer Puglia1, Tan Wang, Christine Smith-Snyder, Marie Cote, Michael Scher, Joelle N Pelletier, Sinu John, Colleen B Jonsson, Monica J Roth.   

Abstract

Linker-scanning libraries were generated within the 3' terminus of the Moloney murine leukemia virus (M-MuLV) pol gene encoding the connection-RNase H domains of reverse transcriptase (RT) as well as the structurally related M-MuLV and human immunodeficiency virus type 1 (HIV-1) integrase (IN) proteins. Mutations within the M-MuLV proviral vectors were Tn7 based and resulted in 15-bp insertions. Mutations within an HIV-1 IN bacterial expression vector were based on Tn5 and resulted in 57-bp insertions. The effects of the insertions were examined in vivo (M-MuLV) and in vitro (HIV-1). A total of 178 individual M-MuLV constructs were analyzed; 40 in-frame insertions within RT connection-RNase H, 108 in-frame insertions within IN, 13 insertions encoding stop codons within RNase H, and 17 insertions encoding stop codons within IN. For HIV-1 IN, 56 mutants were analyzed. In both M-MuLV and HIV-1 IN, regions are identified which functionally tolerate multiple-linker insertions. For MuLV, these correspond to the RT-IN proteolytic junction, the junction between the IN core and C terminus, and the C terminus of IN. For HIV-1 IN, in addition to the junction between the IN core and C terminus and the C terminus of IN, insertions between the N terminus and core domains maintained integration and disintegration activity. Of the 40 in-frame insertions within the M-MuLV RT connection-RNase H domains, only the three C-terminal insertions mapping to the RT-IN proteolytic junction were viable. These results correlate with deletion studies mapping the domain and subdomain boundaries of RT and IN. Importantly, these genetic footprints provide a means to identify nonessential regions within RT and IN for targeted gene therapy applications.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16973554      PMCID: PMC1617218          DOI: 10.1128/JVI.00856-06

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  92 in total

1.  Characterization of intracellular reverse transcription complexes of human immunodeficiency virus type 1.

Authors:  A Fassati; S P Goff
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

2.  Solution structure of the N-terminal zinc binding domain of HIV-1 integrase.

Authors:  M Cai; R Zheng; M Caffrey; R Craigie; G M Clore; A M Gronenborn
Journal:  Nat Struct Biol       Date:  1997-07

3.  A previously unidentified host protein protects retroviral DNA from autointegration.

Authors:  M S Lee; R Craigie
Journal:  Proc Natl Acad Sci U S A       Date:  1998-02-17       Impact factor: 11.205

4.  Second-site changes affect viability of amphotropic/ecotropic chimeric enveloped murine leukemia viruses.

Authors:  L O'Reilly; M J Roth
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

5.  Domain structure of the Moloney murine leukemia virus reverse transcriptase: mutational analysis and separate expression of the DNA polymerase and RNase H activities.

Authors:  N Tanese; S P Goff
Journal:  Proc Natl Acad Sci U S A       Date:  1988-03       Impact factor: 11.205

6.  Selective extraction of polyoma DNA from infected mouse cell cultures.

Authors:  B Hirt
Journal:  J Mol Biol       Date:  1967-06-14       Impact factor: 5.469

7.  Directed integration of viral DNA mediated by fusion proteins consisting of human immunodeficiency virus type 1 integrase and Escherichia coli LexA protein.

Authors:  H Goulaouic; S A Chow
Journal:  J Virol       Date:  1996-01       Impact factor: 5.103

8.  Genetic analyses of conserved residues in the carboxyl-terminal domain of human immunodeficiency virus type 1 integrase.

Authors:  Richard Lu; Hina Z Ghory; Alan Engelman
Journal:  J Virol       Date:  2005-08       Impact factor: 5.103

9.  Genetic footprinting of the HIV co-receptor CCR5: delineation of surface expression and viral entry determinants.

Authors:  Ricardo Quinonez; Indu Sinha; Ila R Singh; Richard E Sutton
Journal:  Virology       Date:  2003-03-01       Impact factor: 3.616

10.  The barrier-to-autointegration factor is a component of functional human immunodeficiency virus type 1 preintegration complexes.

Authors:  Chou-Wen Lin; Alan Engelman
Journal:  J Virol       Date:  2003-04       Impact factor: 5.103

View more
  19 in total

1.  Protein transduction from retroviral Gag precursors.

Authors:  Christine Voelkel; Melanie Galla; Tobias Maetzig; Eva Warlich; Johannes Kuehle; Daniela Zychlinski; Juergen Bode; Tobias Cantz; Axel Schambach; Christopher Baum
Journal:  Proc Natl Acad Sci U S A       Date:  2010-04-12       Impact factor: 11.205

2.  Subunit-specific protein footprinting reveals significant structural rearrangements and a role for N-terminal Lys-14 of HIV-1 Integrase during viral DNA binding.

Authors:  Zhuojun Zhao; Christopher J McKee; Jacques J Kessl; Webster L Santos; Janet E Daigle; Alan Engelman; Gregory Verdine; Mamuka Kvaratskhelia
Journal:  J Biol Chem       Date:  2007-12-19       Impact factor: 5.157

3.  In vivo biotinylation and capture of HIV-1 matrix and integrase proteins.

Authors:  Michael Belshan; Cameron J Schweitzer; Meghan R Donnellan; Richard Lu; Alan Engelman
Journal:  J Virol Methods       Date:  2009-03-26       Impact factor: 2.014

4.  Human T-cell leukemia virus type 1 integration target sites in the human genome: comparison with those of other retroviruses.

Authors:  David Derse; Bruce Crise; Yuan Li; Gerald Princler; Nicole Lum; Claudia Stewart; Connor F McGrath; Stephen H Hughes; David J Munroe; Xiaolin Wu
Journal:  J Virol       Date:  2007-04-04       Impact factor: 5.103

5.  Transcription factor YY1 interacts with retroviral integrases and facilitates integration of moloney murine leukemia virus cDNA into the host chromosomes.

Authors:  Yujin Inayoshi; Yuuki Okino; Katsuhide Miyake; Akifumi Mizutani; Junko Yamamoto-Kishikawa; Yuya Kinoshita; Yusuke Morimoto; Kazuhito Imamura; Mahboob Morshed; Ken Kono; Toshinari Itoh; Ken-ichi Nishijima; Shinji Iijima
Journal:  J Virol       Date:  2010-06-02       Impact factor: 5.103

6.  Expression artifact with retroviral vectors based on pBMN.

Authors:  Yoshitaka Fukunaga; Robert A Svoboda; Ronald L Cerny; Keith R Johnson; Margaret J Wheelock
Journal:  Anal Biochem       Date:  2009-07-12       Impact factor: 3.365

Review 7.  Murine leukemia virus reverse transcriptase: structural comparison with HIV-1 reverse transcriptase.

Authors:  Marie L Coté; Monica J Roth
Journal:  Virus Res       Date:  2008-02-21       Impact factor: 3.303

Review 8.  Ribonuclease H: properties, substrate specificity and roles in retroviral reverse transcription.

Authors:  James J Champoux; Sharon J Schultz
Journal:  FEBS J       Date:  2009-02-18       Impact factor: 5.542

9.  Defining the DNA substrate binding sites on HIV-1 integrase.

Authors:  James Dolan; Aiping Chen; Irene T Weber; Robert W Harrison; Jonathan Leis
Journal:  J Mol Biol       Date:  2008-11-07       Impact factor: 5.469

Review 10.  RNase H activity: structure, specificity, and function in reverse transcription.

Authors:  Sharon J Schultz; James J Champoux
Journal:  Virus Res       Date:  2008-02-07       Impact factor: 3.303

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.